R1 RCM (RCM) Given News Sentiment Score of 0.23

News coverage about R1 RCM (NASDAQ:RCM) has been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies positive and negative news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. R1 RCM earned a news impact score of 0.23 on Accern’s scale. Accern also assigned media coverage about the financial services provider an impact score of 45.7704538519839 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Here are some of the headlines that may have effected Accern Sentiment’s rankings:

R1 RCM (NASDAQ:RCM) traded up $0.46 on Friday, hitting $5.28. 315,599 shares of the stock were exchanged, compared to its average volume of 207,382. R1 RCM has a one year low of $2.02 and a one year high of $5.43. The firm has a market cap of $551.84, a P/E ratio of -18.86 and a beta of -0.41.

RCM has been the topic of several research analyst reports. BidaskClub raised shares of R1 RCM from a “hold” rating to a “buy” rating in a research report on Thursday, January 11th. Zacks Investment Research lowered shares of R1 RCM from a “hold” rating to a “sell” rating in a report on Wednesday, January 17th.

COPYRIGHT VIOLATION NOTICE: “R1 RCM (RCM) Given News Sentiment Score of 0.23” was originally published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this story on another website, it was illegally stolen and reposted in violation of United States and international copyright law. The correct version of this story can be accessed at https://ledgergazette.com/2018/02/19/somewhat-favorable-media-coverage-somewhat-unlikely-to-affect-r1-rcm-rcm-stock-price.html.

About R1 RCM

R1 RCM Inc is a provider of revenue cycle management (RCM) and physician advisory services (PAS) to healthcare providers. The Company is engaged in providing management services of revenue cycle operations for the United States-based hospitals and other medical services providers. Its primary service offering consists of end-to-end RCM, which the Company deploys through a co-managed relationship or an operating partner relationship.

Insider Buying and Selling by Quarter for R1 RCM (NASDAQ:RCM)

Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply